chartexchange

ESLAW
Estrella Immunopharma, Inc. Warrant
stockNASDAQWarrant

At CloseNov 18, 2026
0.0612USD-2.080%(-0.0013)5,000

ESLAW Financials

In Q3 FY 2026 (ended ), Estrella Immunopharma, Inc. Warrant (ESLAW) reported net income of −$7.38M, operating cash flow of −$217.21K, and assets of $1.67M (filed ).

Loading financial statements…